NASDAQ · BLRX
BioLineRx Ltd.
Healthcare · Biotechnology
$2.32
Down-$0.03 (-1.19%)
Updated Oct 6, 2026, 10:59 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 14.09M
- P/E ratio
- -1.61
- Dividend yield
- 0.00%
- 52-week range
- $2.15 – $4.56
- Volume
- 20.26K
- Avg. volume
- 34.05K
Price performance · BLRX
BLRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
BLRX closed at $2.32 after 20 trading sessions, down 10.42% for the selected period.
- Last close
- $2.32
- Period change
- -10.42%
- Period low
- $2.32
- Period high
- $2.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $2.36 | $2.36 | $2.29 | $2.32 | 20.26K |
| Oct 2, 2026 | $2.31 | $2.37 | $2.31 | $2.37 | 3.13K |
| Oct 1, 2026 | $2.32 | $2.3886 | $2.32 | $2.35 | 7.58K |
| Sep 30, 2026 | $2.36 | $2.395 | $2.30 | $2.35 | 40.78K |
| Sep 29, 2026 | $2.41 | $2.495 | $2.36 | $2.36 | 12.08K |
| Sep 28, 2026 | $2.50 | $2.50 | $2.41 | $2.43 | 12.56K |
| Sep 25, 2026 | $2.49 | $2.60 | $2.49 | $2.60 | 9.89K |
| Sep 24, 2026 | $2.56 | $2.59 | $2.44 | $2.52 | 11.54K |
| Sep 23, 2026 | $2.53 | $2.572 | $2.4503 | $2.56 | 12.67K |
| Sep 22, 2026 | $2.48 | $2.5995 | $2.42 | $2.43 | 10.35K |
| Sep 21, 2026 | $2.53 | $2.5843 | $2.4482 | $2.48 | 17.13K |
| Sep 18, 2026 | $2.50 | $2.51 | $2.4401 | $2.487 | 2.75K |
| Sep 17, 2026 | $2.63 | $2.63 | $2.43 | $2.53 | 11.87K |
| Sep 16, 2026 | $2.52 | $2.54 | $2.476 | $2.48 | 4.35K |
| Sep 15, 2026 | $2.50 | $2.545 | $2.45 | $2.52 | 29.11K |
| Sep 14, 2026 | $2.52 | $2.52 | $2.43 | $2.43 | 21.21K |
| Sep 11, 2026 | $2.575 | $2.62 | $2.50 | $2.51 | 9.54K |
| Sep 10, 2026 | $2.53 | $2.63 | $2.52 | $2.5695 | 8.13K |
| Sep 9, 2026 | $2.59 | $2.59 | $2.53 | $2.55 | 7.74K |
| Sep 8, 2026 | $2.78 | $2.78 | $2.55 | $2.59 | 19.85K |
Latest BLRX news
The latest Smart Investors Daily articles mentioning BLRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…
